Correlation Between Burzynski Research and Oncology Pharma
Can any of the company-specific risk be diversified away by investing in both Burzynski Research and Oncology Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Burzynski Research and Oncology Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Burzynski Research and Oncology Pharma, you can compare the effects of market volatilities on Burzynski Research and Oncology Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Burzynski Research with a short position of Oncology Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Burzynski Research and Oncology Pharma.
Diversification Opportunities for Burzynski Research and Oncology Pharma
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Burzynski and Oncology is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Burzynski Research and Oncology Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncology Pharma and Burzynski Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Burzynski Research are associated (or correlated) with Oncology Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncology Pharma has no effect on the direction of Burzynski Research i.e., Burzynski Research and Oncology Pharma go up and down completely randomly.
Pair Corralation between Burzynski Research and Oncology Pharma
Given the investment horizon of 90 days Burzynski Research is expected to generate 127.32 times less return on investment than Oncology Pharma. But when comparing it to its historical volatility, Burzynski Research is 23.35 times less risky than Oncology Pharma. It trades about 0.05 of its potential returns per unit of risk. Oncology Pharma is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 0.01 in Oncology Pharma on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Oncology Pharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Burzynski Research vs. Oncology Pharma
Performance |
| Timeline |
| Burzynski Research |
| Oncology Pharma |
Burzynski Research and Oncology Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Burzynski Research and Oncology Pharma
The main advantage of trading using opposite Burzynski Research and Oncology Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Burzynski Research position performs unexpectedly, Oncology Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncology Pharma will offset losses from the drop in Oncology Pharma's long position.| Burzynski Research vs. ProKidney Corp | Burzynski Research vs. Orchestra BioMed Holdings | Burzynski Research vs. Lixte Biotechnology Holdings | Burzynski Research vs. Oncology Pharma |
| Oncology Pharma vs. Regen BioPharma | Oncology Pharma vs. Regen BioPharma | Oncology Pharma vs. Therapeutic Solutions International | Oncology Pharma vs. Alpha Cognition |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |